Applications

Inflixmab F(ab)2 80°

Analytes

1Infliximab

Analyte not found

Details

LC Conditions (App ID: 24690)

Column:

bioZen 3.6 µm Intact XB-C8, LC Column 150 x 2.1 mm, Ea

Brand Name:

bioZen

Part No:

00F-4766-AN

Phase Name:

Intact XB-C8

Elution Type:

Gradient

Mobile Phase:

A: 0.1% TFA in water

B: 0.1% TFA in acetonitrile

Gradient Profile:

Step No.	Time(min)	%A	%B
1	0	80	20
2	1	80	20
3	13	40	60

Flow Rate:

0.5 mL/min

Temperature:

80°C

Detection:

UV-Vis Abs.-Variable Wave.(UV) @ 280 nm (22°C)

Order Items Used in This Application

00F-4766-AN

bioZen 3.6 µm Intact XB-C8, LC Column 150 x 2.1 mm, Ea

Qty:

infoSign in to view country specific pricing

Similar Applications

Select Analyte of Interest

Infliximab Peptide Mapping with Tryptic Digest on bioZen 1.6 µm Peptide PS-C18

bioZen 1.6 µm Peptide PS-C18, LC Column 150 x 2.1 mm, Ea

Reversed Phase

Infliximab Peptide Mapping with Tryptic Digest on bioZen 2.6 µm Peptide XB-C18

bioZen 2.6 µm Peptide XB-C18, LC Column 150 x 2.1 mm, Ea

Reversed Phase

Infliximab-dyyb Triplicate Injections on bioZen 1.8 um SEC-3

bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea

Gel Filtration Chromatography (GFC)

Infliximab-abda on bioZen SEC-3

bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea

Gel Filtration Chromatography (GFC)

Infliximab on bioZen 1.8 µm SEC-3

bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea

Gel Filtration Chromatography (GFC)

Infliximab on bioZen 1.8 µm SEC-3

bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea

Gel Filtration Chromatography (GFC)

Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.

CONNECT WITH US

PRODUCTS AND SERVICES

SUPPORT

Product/Method Support

Product Troubleshooting

OUR COMPANY

Danaher Life Sciences

Applications

Inflixmab F(ab)2 80°

Order Items Used in This Application

App ID 24690

Order Items Used in This Application